AXQ Capital’s Protara Therapeutics TARA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$128K Buy
+41,904
New +$163K 0.02% 847
2026
Q2
– Sell
-13,002
Closed -$67.7K – 1339
2026
Q1
$67.7K Buy
13,002
+2,187
+20% +$12.9K 0.01% 911
2025
Q4
$57.6K Buy
+10,815
New +$60.1K 0.01% 685

Other funds holding TARA

AXQ Capital's TARA Position: Q3 2026 in Review

AXQ Capital opened a new position in Protara Therapeutics (TARA) in Q3 2026: 41,904 shares worth $128K. The stake represents 0.02% of the portfolio and ranks #847 among its holdings. This is a return to the name: AXQ Capital previously reported a position in TARA as recently as Q1 2026.

AXQ Capital first reported a position in TARA in Q4 2025 and has held it in 3 quarters since. 119 funds tracked by Wall St. Rank hold TARA as of Q3 2026.

  • AXQ Capital held 41,904 shares of Protara Therapeutics worth $128K as of Q3 2026.
  • Protara Therapeutics was a new AXQ Capital position in Q3 2026.
  • Protara Therapeutics made up 0.02% of AXQ Capital's portfolio in Q3 2026, its #847 holding.
  • AXQ Capital first reported a position in Protara Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 119 funds tracked by Wall St. Rank held Protara Therapeutics as of Q3 2026.

Based on AXQ Capital's 13F filing for Q3 2026, filed 12 Nov 2026.